National Pharmaceutical Council Comments On Patient-Centered Outcomes Research Institute Board of Governors

U.S. Newswire › September 23, 2010

Linked as:

Summary

WASHINGTON, Sept. 23 /PRNewswire-USNewswire/ -- National Pharmaceutical Council (NPC) President Dan Leonard today commented on the appointment of the Board of Governors for the Patient- Centered Outcomes Research Institute (PCORI), a private, non-profit corporation created by the health reform law to develop and fund comparative effectiveness research (CER).

"The decisions made by this first PCORI board will have a significant impact on the future of CER and its utility for health care decision makers," said Leonard. "After all, this board, along with the methodology committee, will be setting the framework for determining CER priorities, developing sound standards and methodologies for data and research, and translating research results in a useful and understandable way."

See the full content of this document

Extract

National Pharmaceutical Council Comments On Patient-Centered Outcomes Research Institute Board of Governors

Leonard also outlined some general principles to ensure that CER will work to provide the best health outcomes ...

See the full content of this document